Regenexx LLC is a leading provider of non-surgical orthopedic and spine procedures that utilize the body's natural healing process to promote regeneration and repair of damaged tissues.
Regenexx was founded in 2005 by Dr. Chris Centeno, a pioneer in the field of regenerative medicine.
The company has since grown to become the world's largest provider of orthopedic stem cell procedures, with over 100 locations in the United States and abroad.
Celling Biosciences is a Texas-based company that develops and manufactures regenerative medicine products.
MiMedx is a biopharmaceutical company that develops and markets regenerative biomaterials and bioimplants.
Osiris Therapeutics is a Maryland-based company that develops and markets regenerative medicine products for orthopedics, sports medicine, and wound care.
Regenexx-SD is a same-day stem cell procedure that uses the patient's own stem cells to promote tissue repair and regeneration. It is used to treat a variety of orthopedic conditions, including arthritis, joint and ligament injuries, and spinal disc degeneration.
Regenexx-C is a platelet-rich plasma (PRP) therapy that uses the patient's own blood to promote healing of damaged tissues. It is used to treat a variety of orthopedic conditions, including tendon and ligament injuries, arthritis, and joint pain.
Regenexx-SCP is a concentrated stem cell procedure that uses the patient's own stem cells to promote tissue repair and regeneration. It is used to treat a variety of orthopedic conditions, including arthritis, joint and ligament injuries, and spinal disc degeneration.
Regenexx is a provider of non-surgical orthopedic and spine procedures that utilize the body's natural healing process to promote regeneration and repair of damaged tissues. The procedures use the patient's own stem cells or blood to promote healing and are performed in a same-day outpatient setting.
Regenexx procedures are usually not covered by insurance, although some patients may be able to obtain partial reimbursement from their insurance provider. The company's website provides information on financing options and payment plans.
Regenexx procedures are generally well tolerated by patients and usually involve only mild discomfort or soreness. Patients are typically able to return to normal activities within a few days after the procedure.
The results of a Regenexx procedure vary depending on the type and severity of the condition being treated. Some patients may begin to experience relief within a few weeks after the procedure, while others may take several months to see significant improvement.
Regenexx procedures are generally considered safe and effective alternatives to surgery for certain orthopedic and spine conditions. The procedures are minimally invasive and do not require general anesthesia, reducing the risk of complications and the need for a lengthy recovery period.